Aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of $3.41 per share versus the Zacks Consensus Estimate of a loss of $1.91. This compares to loss of $5.50 per share a year ago.

ALIGOS THERAPEUTICS ($ALGS) is expected to release its quarterly earnings data on Monday, March 10th before market open, per Finnhub. Analysts are expecting revenue ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Aligos Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses ...

With the Apex Legends Global Series Year 4 Championship having reached its end a couple of weeks ago, the players have started prepping for the next year. While several pro players are deciding to ...

UK organisation Noctem Esports announces closure after two years of Apex Legends and Call of Duty competitive play.

The UEFA Champions League knockout stage is underway as the best teams ifight for the most prestigious trophy in European club competition. At the time of writing, just 16 teams remain in the ...

The BCCI has announced a 74-match schedule for the 18th Indian Premier League, starting from March 22. The tournament, featuring 12 double-headers, will be hosted across 13 venues and conclude ...

The Tamil Nadu Teacher Recruitment Board (TN TRB) has announced the schedule for the State Eligibility Test (SET) 2024, set for March 6, 7, 8, and 9, 2025. The exam, conducted in a Computer-Based ...

Want to know what fights are on the horizon? Check out the boxing schedule for 2024. For a list of the current champions in all weight classes, click here. To go directly to a particular month ...

With the inaugural regular season ending Tuesday night, the first-ever TGL playoffs are set to begin. Given that the TGL is a brand-new indoor golf league, the playoffs will feature a unique ...

A new presidential commission will scrutinize the childhood vaccine schedule as a potential cause of the country’s chronic disease epidemic, Health and Human Services Secretary Robert F.